Navigation Links
Cell Genesys to Webcast Third Quarter 2007 Conference Call
Date:10/25/2007

SOUTH SAN FRANCISCO, Calif., Oct. 25 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE), today announced that Stephen A. Sherwin, M.D., chairman and chief executive officer, and Sharon E. Tetlow, senior vice president and chief financial officer of Cell Genesys, will host a conference call relating to the company's third quarter financial results that will be broadcast live over the internet on Thursday, November 1, 2007, at 2:00 p.m. PT/ 5:00 p.m. ET.

The webcast will be available on the investor relations section of the company's website, http://www.cellgenesys.com. If you are unable to listen to the live webcast, the call will be archived on the website for at least 72 hours following the call. To access the replay, go to the Investor Relations section of the website.

Cell Genesys is focused on the development and commercialization of novel biological therapies for patients with cancer. The company is currently pursuing two clinical stage product platforms -- GVAX(TM) cancer immunotherapies and oncolytic virus therapies. Ongoing clinical trials include Phase 3 trials of GVAX immunotherapy for prostate cancer, Phase 2 trials of GVAX immunotherapies for pancreatic cancer and for leukemia, and a Phase 1 trial of CG0070 oncolytic virus therapy for bladder cancer. Cell Genesys continues to hold an equity interest in its former subsidiary, Ceregene, Inc., which is developing gene therapies for neurodegenerative disorders. Cell Genesys is headquartered in South San Francisco, CA and has its principal manufacturing operation in Hayward, CA. For additional information, please visit the company's website at '/>"/>

SOURCE Cell Genesys, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sonic Foundry to Webcast Bridge Arch Floating Down Mississippi
2. Visions: Broderick says Wisconsin should be in top third in venture capital
3. Third Wave files countersuit vs. Digene in patent case
4. Third Wave reports net loss of $18.9M for 2006
5. Stratagene to pay Third Wave $10.75M in patent case
6. Third Wave responds to Digene patent lawsuit
7. Third Wave seeks approval of Cystic Fibrosis test
8. Third Wave Technologies to raise $14.9M through private debt
9. Venture capital above $6B for third straight quarter
10. Third Wave reports $5.2M third quarter loss
11. Third Wave reports another loss, stronger sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 2014 Today the National Institutes ... grants for the Brain Research through Advancing Innovative ... develop and revolutionize new methods of understanding the ... brain. This first round of grants totaling $46 ... allocated to more than 100 investigators in 15 ...
(Date:10/1/2014)... Francisco, California (PRWEB) October 01, 2014 ... from the National Science Foundation to expand their bioCAD/CAM ... to build and modify DNA. The Small Business Innovation ... commercialize the “j5” technology under exclusive license from the ... Joint BioEnergy Institute , an LBNL laboratory that ...
(Date:9/30/2014)... D.C., September 30, 2014 Applying a well-known ... researchers at Harvard University has demonstrated the ability ... -- work that holds promise for making future, ... detailing the sides of next-gen rocket ships and ... light passes through oil in water, it becomes ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Shimadzu ... extensometer, an easy-to-use and highly precise tool for ... with considerable elongation. With 1000-mm maximum movement distance, ... percent for a gauge length of 10 mm. ... measurement accuracy above 50-mm stroke and within +/- ...
Breaking Biology Technology:NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 2NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 3TeselaGen Receives $750k NSF SBIR Phase II Award 2TeselaGen Receives $750k NSF SBIR Phase II Award 3Taking thin films to the extreme 2Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2
... transplanting them may hold the key to optimizing stem ... Research published in BioMed Central,s open access Journal ... for victims of paralysis to recover the use of ... syndromes. , Dr. Stephen Davies, Associate Professor of Neurosurgery ...
... 19 Boston Scientific,Corporation (NYSE: BSX ) is ... which is being held September 22 - 25 in ... Officer, will make a,30-minute presentation which will be followed ... 25, beginning at approximately 9:00,a.m. ET., A live ...
... Inc. (OTC Bulletin Board: CHBT) (,China-Biotics," "the,Company"), ... manufacture,research, development, marketing and distribution of probiotics ... General Meeting of Shareholders,(the ,AGM,), stockholders re-elected ... of Directors., At the meeting, held ...
Cached Biology Technology:Breakthrough in spinal injury treatment 2China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders 2
(Date:9/30/2014)... trouble getting pregnanteven with IVF? Here,s some hope: A ... The FASEB Journal , explains how ... known as PAWP, which induced embryo development in human ... embryo development by the sperm cell during fertilization. , ... a major paradigm shift in our understanding of human ...
(Date:9/30/2014)... a suite of perilous threats in today,s ocean. ... climate change, fragile coral ecosystems are disappearing at ... some species of corals surrounding the island of ... in their tropical environment: coral guard-crabs. New research ... Marine Station scientist Seabird McKeon and the museum,s ...
(Date:9/29/2014)... gut bacteria called Clostridium ramosum , coupled with a ... is published this week in mBio , the online ... A research team from the German Institute of Human Nutrition ... including C. ramosum gained weight when fed a ... were less obese even when consuming a high-fat diet, ...
Breaking Biology News(10 mins):Synthetic sperm protein raises the chance for successful in vitro fertilization 2Smithsonian scientists discover coral's best defender against an army of sea stars 2Gut bacteria promote obesity in mice 2
... have learned to glide through the forest, from flying ... as it sounds ?snakes. , Now, add ants to ... Berkeley, and the University of Texas Medical Branch in ... known to actively direct their fall ?were first observed ...
... analysis published in the Feb. 8 PNAS supports the ... , Researchers in California, Israel, and Germany have compared ... the fruit fly ?and reported that protein "wiring" connections ... This first-of-its-kind analysis of three higher level organisms published ...
... building blocks of life--is exploding as scientists worldwide discover ... the development of organisms. The rapidly growing body of ... a shared vocabulary and system for describing, cataloging and ... scientists, known as the RNA Ontology Consortium, has now ...
Cached Biology News:Falling ants glide back to trunk to avoid dangers of forest floor 2Falling ants glide back to trunk to avoid dangers of forest floor 3Falling ants glide back to trunk to avoid dangers of forest floor 4Falling ants glide back to trunk to avoid dangers of forest floor 5Examination of internal 'wiring' of yeast, worm, and fly reveals conserved circuits 2Examination of internal 'wiring' of yeast, worm, and fly reveals conserved circuits 3Examination of internal 'wiring' of yeast, worm, and fly reveals conserved circuits 4RNA project to create language for scientists worldwide 2RNA project to create language for scientists worldwide 3
Goat Anti-Horse IgG(T) Antibody, Unconjugated...
Goat polyclonal to STMN2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AKTAMAYKEK, corresponding to C terminal amino acids 2-11 of STMN2. Entrez Gene ID: 11075 Swi...
Mouse monoclonal antibody to RNase L...
Anti (porcine) Vitronectin...
Biology Products: